Therapeutic Solutions International Inc (TSOI)

[centsability4me]

TSOI Science leads the way on QuadraMune


NEWS 5/5/20
Therapeutic Solutions International Leverages Filed and Issued Intellectual Property to Develop COVID-19 Nutraceutical
https://ih.advfn.com/stock-market/USOTC/therapeutic-solutions-pk-TSOI/stock-news/82379211/therapeutic-solutions-international-leverages-file

Therapeutic Solutions International Leverages Filed and Issued Intellectual Property to Develop COVID-19 Nutraceutical Candidate: QuadraMune™
Company Intends to Initiate Clinical Trials using Novel "Multipronged" Attack on Coronavirus Pathology



NEWS 6/1/20
San Diego Top Doctor Collaborates with Therapeutic Solutions International to Report QuadraMune™ Immune Boosting Data in Clinical Trial
Scientifically Formulated Nutraceutical Product Appears to Stimulate Natural Killer Cell Arm of Immune System Responsible for Suppression of Cancer and Viruses

https://ih.advfn.com/stock-market/USOTC/therapeutic-solutions-pk-TSOI/stock-news/82572735/san-diego-top-doctor-collaborates-with-therapeutic

NEWS 6/4/20
Therapeutic Solutions International Announces Positive Preclinical and Clinical Evaluation of Nutritional Supplement QuadraMune™, Designed to Protect Against COVD-19
Company Submits Results of Clinical Trial for Publication in Peer-Reviewed Medical Journal
https://ih.advfn.com/stock-market/USOTC/therapeutic-solutions-pk-TSOI/stock-news/82600993/therapeutic-solutions-international-announces-posi

NEWS 6/8/20
Therapeutic Solutions International Initiates 500 Volunteer COVID-19 Prevention Clinical Trial Using QuadraMune™
San Diego Top Doctor James Veltmeyer Leads Efforts to Demonstrate Efficacy of Immune Boosting Formulation in High-Risk Population
https://ih.advfn.com/stock-market/USOTC/therapeutic-solutions-pk-TSOI/stock-news/82617340/therapeutic-solutions-international-initiates-500

NEWS 6/11/20
Therapeutic Solutions International Reports QuadraMune Reduces Myeloid Suppressor Cells in 4T1 Mouse Model of Breast Cancer
New Patent Filing Suggests Novel Mechanism of Immune Boosting Nutraceutical Can Augment Efficacy of Cancer Immunotherapy
https://ih.advfn.com/stock-market/USOTC/therapeutic-solutions-pk-TSOI/stock-news/82642329/therapeutic-solutions-international-reports-quadra

NEWS 6/15/20
Therapeutic Solutions International Reports Reduction of Brain Inflammation/Depression Associated Biochemical Pathway Using QuadraMune™ in Animal Studies

Continued Basic Science Experiments Support New Patent Filing Covering Suppression of Indolamine 2,3 Deoxygenase Pathway by QuadraMune™
https://ih.advfn.com/stock-market/USOTC/therapeutic-solutions-pk-TSOI/stock-news/82657747/therapeutic-solutions-international-reports-reduct